ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "informatics"

  • Abstract Number: 1745 • ACR Convergence 2020

    A Novel Method for Predicting 1-Year Retention of Abatacept Using Machine Learning Techniques

    Rieke Alten1, Claire Behar2, Christine Boileau2, Pierre Merckaert2, Ebenezer Afari2, Virginie Vannier-Moreau3, Sean Connolly3, Yedid Elbez2, Pierre-Antoine Juge4 and Karissa Lozenski3, 1Schlosspark-Klinik, Universitätsmedizin, Berlin, Germany, 2Excelya, Boulogne-Billancourt, France, 3Bristol-Myers Squibb Company, Princeton, NJ, 4Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France

    Background/Purpose: In the ACTION (NCT02109666) study, using multivariable Cox proportional hazards regression models, patient (pt) global assessment of pain, country, reason for stopping last biologic,…
  • Abstract Number: 1788 • ACR Convergence 2020

    Assessment of the Impact of Interferon Levels on Cognitive Dysfunction in Patients with SLE

    Andrew Kwan1, Joan Wither2, Juan Pablo Diaz-Martinez2, Robin Green3, Dorcas Beaton4, Mahta Kakvan2, Lesley Ruttan3, Carmela Tartaglia5, Marvin Fritzler6, May Choi7, Jiandong Su2, Dennisse Bonilla2, Nicole Anderson2, Patricia Katz8 and Zahi Touma9, 1University of Toronto, Department of Medicine, Toronto, ON, Canada, 2University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 3Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada, 4Institute for Work & Health, Toronto, ON, Canada, 5University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, 6Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 7Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 8University of California, San Francisco, Novato, CA, 9University of Toronto, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment (CI) is among the earliest and the most prevalent manifestations of SLE. Previous studies have demonstrated that the increased levels of interferon…
  • Abstract Number: 0167 • ACR Convergence 2020

    Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program

    Jonathan Patterson1, Kirby Magid2, Dhiren Patel3 and Matt Allison3, 1Pack Health, Birmingham, AL, 2University of North Carolina at Charlotte, Charlotte, 3Pack Health, Birmingham

    Background/Purpose: The goal of this study was to examine whether cluster analysis could be used to identify homogeneous subgroups of engagement in RA patients enrolled…
  • Abstract Number: 0257 • ACR Convergence 2020

    Application of Text Mining Methods to Identify Lupus Nephritis from Electronic Health Records

    Milena Gianfrancesco1, Suzanne Tamang2, Gabriela Schmajuk3 and Jinoos Yazdany4, 1University of California, San Francisco, San Francisco, CA, 2Stanford Center for Population Health Sciences, Redwood City, CA, 3University of California, San Francisco, Atherton, CA, 4UCSF, San Francisco, CA

    Background/Purpose: Lupus nephritis (LN) is a frequent complication of SLE and associated with higher morbidity and mortality. Accurate estimates of the prevalence of LN in…
  • Abstract Number: 0569 • ACR Convergence 2020

    Ability and Willingness to Utilize Telemedicine Among Rheumatology Patients – a Cross Sectional Survey

    Steve Kong1, Lilian Otalora Rojas2, Amnie Ashour3, Mathew Robinson1 and Neha Bhanusali1, 1University of Central Florida College of Medicine, Orlando, 2University of Central Florida HCA Healthcare GME, Orlando, 3Stony Brook University School of Medicine, New York

    Background/Purpose: Telemedicine (TM) is the delivery of health care services using information and communication technologies. TM presents unique opportunities and benefits specifically in rheumatology as…
  • Abstract Number: 2888 • 2019 ACR/ARP Annual Meeting

    Deriving Accurate Prednisone Dosing from Electronic Health Records: Analysis of a Natural Language Processing Tool for Complex Prescription Instructions

    Francine Castillo1, Adrienne Strait 2, Michael Evans 3, Julia Kay 4, Milena Gianfrancesco 5, Zara Izadi 6, Laura Trupin 1, Mylien Hoang 7, James Shalaby 8, Gabriela Schmajuk 9 and Jinoos Yazdany 4, 1University of California, San Francisco, San Francisco, CA, 2UCSF School of Medicine, San Francisco, CA, 3University of California San Francisco, San Francisco, 4UCSF Division of Rheumatology, San Francisco, CA, 5University of California, San Francisco, San Francisco, 6UCSF Division of Rheumatology, San Francisco, 7Touro University, San Francisco, 8Elimu Informatics, San Francisco, 9UCSF, SFVAMC Division of Rheumatology, San Francisco, CA

    Background/Purpose: Prednisone is commonly used to treat rheumatic diseases, yet few comparative effectiveness studies on different dosing regimens are available. Electronic health records (EHR) and…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology